Today’s health care institutions are stretched to capacity and beyond by the COVID-19 crisis. But like physical exercise, it’s possible that this stress can lead us to a stronger system longer-term. This depends, of course, on how we respond to the shortcomings revealed by our slow responses to the pandemic.From my decades in health policy, […]
Has “Value” in Health Care Stagnated?
The future of value-based purchasing (VBP) is uncertain. Current models have theoretical promise, but critics point to minimal achievements. Despite the rhetoric around paying for value over volume, the percent of health care spending involved in pay-for-performance contracts has stagnated or declined. In addition, the polled enthusiasm among health care industry leaders for value-based purchasing is declining. […]
NCHC Writes Letter to CMS Supporting CMMI
We recently expressed cautious support for the CMMI Geographic Direct Provider Contracting model in a letter to CMS. New opportunities for physician groups, health plans, and other organizations to partner to serve Medicare, and Medicare and Medicaid dual-eligible beneficiaries could bring new innovations in care delivery to more beneficiaries. As the number of alternative payment […]
Insulin: the Life Saving Drug that Needs to be Affordable
Enough is enough–it is time for Congress to address rising insulin prices. Congress has failed to take any action to address the rising cost of insulin. However, the Protecting Access to Biosimilars Act of 2019, introduced by Rep. Diana DeGette (D-CO) in early April, is a promising first step to address the issue. The Energy […]
Reflections on Binding Arbitration Briefing
As Congress and the Trump Administration consider policies to address rising prescription drug prices, the National Coalition on Health Care (NCHC) hosted a Capitol Hill briefing on March 15th to put one promising option on the table: the use of binding arbitration in Medicare Part D to determine prices for a limited set of drugs. […]
- 1
- 2
- 3
- …
- 11
- Next Page »